Comparing plasma ptau217 with CSF biomarkers for predicting tau PET status

Gemma Salvadó, PhD, Lund University, Lund, Sweden, compares plasma ptau217 with cerebrospinal fluid (CSF) biomarkers for predicting tau positron emission tomography (PET) status. She mentions that ptau217 is a better predictor of tau PET status than CSF biomarkers, and ptau217 is well correlated with both amyloid and tau at different thresholds. This interview took place at the Alzheimer’s Association International Conference® (AAIC) 2024 in Philadelphia, PA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.